SD Biosensor Files 2025 Corporate Governance Report: Average Compliance with Governance Standards and Ongoing Shareholder Return Policy
SD Biosensor disclosed its 2025 Corporate Governance Report with a compliance rate of 11 out of 15 key indicators (73.3%), considered average.
The board consists of 8 members (3 inside, 5 outside), and all board committees including the audit committee are composed entirely of outside directors, ensuring independence.
The largest shareholder holds 71.65% of shares, while minority shareholders hold 28.35%.
In 2025, consolidated revenue was KRW 710.5B, operating loss KRW 80.9B, and net loss KRW 513.4B, continuing losses.
Shareholder returns: In February 2025, the company acquired and fully cancelled 2,728,251 shares (2.19%). In March 2026, an additional 1 million shares were cancelled. A cash dividend of KRW 200 per share (approx. KRW 23.9B) was paid for FY2025.
Mid- to long-term shareholder return policy (2026-2028): At least 20% of separate operating income as dividend source, and annual share acquisition and cancellation of 1 million shares.
[AI Comprehensive Analysis]This report is a routine governance disclosure with no new material events. The governance improvements and shareholder return policy are neutral. However, the sustainability of dividends amid losses and the protection of minority rights under high majority ownership require ongoing attention.